The prevalence of dementia: a systematic review and meta-analysis

Q Cao, CC Tan, W Xu, H Hu, XP Cao… - Journal of …, 2020 - content.iospress.com
Dementia is a severe neurodegenerative disorder and it can be categorized into several
subtypes by different pathogenic causes. We sought to comprehensively analyzed the …

[HTML][HTML] Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study

L Jia, Y Du, L Chu, Z Zhang, F Li, D Lyu, Y Li… - The Lancet public …, 2020 - thelancet.com
Background China has a large population of older people, but has not yet undertaken a
comprehensive study on the prevalence, risk factors, and management of both dementia …

The amyloid cascade hypothesis: an updated critical review

KP Kepp, NK Robakis, PF Høilund-Carlsen, SL Sensi… - Brain, 2023 - academic.oup.com
Results from recent clinical trials of antibodies that target amyloid-β (Aβ) for Alzheimer's
disease have created excitement and have been heralded as corroboration of the amyloid …

Hi-GCN: A hierarchical graph convolution network for graph embedding learning of brain network and brain disorders prediction

H Jiang, P Cao, MY Xu, J Yang, O Zaiane - Computers in Biology and …, 2020 - Elsevier
Purpose Recently, brain connectivity networks have been used for the classification of
neurological disorder, such as Autism Spectrum Disorders (ASD) or Alzheimer's disease …

[HTML][HTML] Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment

AH Meghdadi, M Stevanović Karić, M McConnell… - PloS one, 2021 - journals.plos.org
In this paper, we explore the utility of resting-state EEG measures as potential biomarkers for
the detection and assessment of cognitive decline in mild cognitive impairment (MCI) and …

Active aging and public health: evidence, implications, and opportunities

S Dogra, DW Dunstan, T Sugiyama… - Annual review of …, 2022 - annualreviews.org
By 2050, 20% of the world's population will be over the age of 65 years, with projections that
80% of older adults will be living in low-to middle-income countries. Physical inactivity and …

[HTML][HTML] The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease

M Colom-Cadena, T Spires-Jones, H Zetterberg… - Alzheimer's research & …, 2020 - Springer
Background Synapse damage and loss are fundamental to the pathophysiology of
Alzheimer's disease (AD) and lead to reduced cognitive function. The goal of this review is to …

[HTML][HTML] Novel therapeutic approaches for Alzheimer's disease: an updated review

TW Yu, HY Lane, CH Lin - International journal of molecular sciences, 2021 - mdpi.com
Alzheimer's disease (AD) is a progressive neurodegenerative disease and accounts for
most cases of dementia. The prevalence of AD has increased in the current rapidly aging …

[HTML][HTML] Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European …

RNM Saleh, M Hornberger, CW Ritchie… - Alzheimer's research & …, 2023 - Springer
Background The risk of dementia is higher in women than men. The metabolic
consequences of estrogen decline during menopause accelerate neuropathology in …

[HTML][HTML] Changing demography and the challenge of dementia in India

V Ravindranath, JS Sundarakumar - Nature Reviews Neurology, 2021 - nature.com
In India, increasing lifespan and decreasing fertility rates have resulted in a growing number
of older persons. By 2050, people over 60 years of age are predicted to constitute 19.1% of …